Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics
Development of an Artificial Intelligence Precise Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics
1 other identifier
observational
1,000
1 country
1
Brief Summary
It is a prospective, observational cohort study of patients with dense breast tissue. The study was based on the radiomics and other clinicopathological information of patients to establish the diagnostic system for breast disease by using artificial intelligence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedFirst Posted
Study publicly available on registry
September 2, 2020
CompletedSeptember 2, 2020
August 1, 2020
Same day
August 21, 2020
August 31, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
the predictive model's area under curve(AUC)
To assess the predictive accuracy of the radiomic-based and clinical-based model by using operating characteristic curve (ROC) analysis and calculating the area under the curves (AUC).
follow up for 2 year for individuals
Eligibility Criteria
Female patients aged 18-80 were included in our study who were diagnosed and treated at Sun Yat-sen memorial hospital .
You may qualify if:
- Female patients with dense breast density tissue
- Digital breast tomosynthesis was performed
- Breast ultrasound examination was performed
- Pathologic examination of breast lesions was performed
You may not qualify if:
- Incomplete clinicopathologic data
- Female patients with fatty glands of the breast
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Breast tumor center of Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, 510120, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
August 21, 2020
First Posted
September 2, 2020
Study Start
September 1, 2020
Primary Completion
September 1, 2020
Study Completion
September 1, 2020
Last Updated
September 2, 2020
Record last verified: 2020-08